Myopericarditis in young adults presenting to the emergency department after receiving a second COVID-19 mRNA vaccine
Acad Emerg Med
.
2021 Jul;28(7):802-805.
doi: 10.1111/acem.14307.
Epub 2021 Jul 26.
Authors
Alex Fleming-Nouri
1
,
Adrian D Haimovich
1
,
David Yang
1
,
Wade L Schulz
2
,
Andreas Coppi
3
,
R Andrew Taylor
1
Affiliations
1
Department of Emergency Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
2
Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
3
Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
PMID:
34310793
PMCID:
PMC8441914
DOI:
10.1111/acem.14307
No abstract available
Publication types
Letter
MeSH terms
COVID-19 Vaccines*
COVID-19*
Emergency Service, Hospital
Humans
RNA, Messenger
SARS-CoV-2
Young Adult
Substances
COVID-19 Vaccines
RNA, Messenger
Grants and funding
UL1 TR001863/TR/NCATS NIH HHS/United States